Rejection Surveillance: Integrating Cell-Free DNA and Gene Expression Panels to Decrease Invasiveness in Routine Monitoring of Heart Transplant Recipients
By: Hatem Alansari and Janardhana R. Gorthi
References
- Copeland H, Knezevic I, Baran DA, et al. Donor heart selection: Evidence-based guidelines for providers. J Heart Lung Transplant. 2023 Jan;42(1):7-29. doi: 10.1016/j.healun.2022.08.030
- Briasoulis A, Inampudi C, Pala M, Asleh R, Alvarez P, Bhama J. Induction immunosuppressive therapy in cardiac transplantation: a systematic review and meta-analysis. Heart Fail Rev. 2018 Sep;23(5):641-649. doi: 10.1007/s10741-018-9691-2
- Khush KK, Cherikh WS, Chambers DC, et al.; International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant. 2018 Oct;37(10):1155-1168. doi: 10.1016/j.healun.2018.07.022
- Caves P, Coltart J, Billingham M, Rider A, Stinson E. Transvenous endomyocardial biopsy--application of a method for diagnosing heart disease. Postgrad Med J. 1975 May;51(595):286-90. doi: 10.1136/pgmj.51.595.286
- Crespo-Leiro MG, Zuckermann A, Bara C, et al. Concordance among pathologists in the second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II). Transplantation. 2012 Dec 15;94(11):1172-7. doi: 10.1097/TP.0b013e31826e19e2
- Yilmaz A, Kindermann I, Kindermann M, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation. 2010 Aug 31;122(9):900-9. doi: 10.1161/CIRCULATIONAHA.109.924167
- Seferović PM, Tsutsui H, McNamara DM, et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. Eur J Heart Fail. 2021 Jun;23(6):854-871. doi: 10.1002/ejhf.2190 Erratum in: Eur J Heart Fail. 2022 Apr;24(4):732. doi: https://doi.org/10.1002/ejhf.2474
- Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005 Nov;24(11):1710-20. doi: 10.1016/j.healun.2005.03.019
- Velleca A, Shullo MA, Dhital K, et al. The International Society for Heart and Lung Transplantation (ISHLT) Guidelines for the Care of Heart Transplant Recipients. J Heart Lung Transpl. 2023 May;42(5):e1-141. doi: 10.1016/j.healun.2022.10.015
- Miklin DJ, Ravi K, Shekhtman G, et al. Early Use of Donor Derived Cell-Free DNA (dd-cfDNA) in Heart Transplantation. J Heart Lung Transplant. 2022 Apr;41(4):S445. doi: 10.1016/j.healun.2022.01.1124
- Saeyeldin A, McKean S, Van Zyl J, Darst V, Hall S. A modern heart transplant rejection surveillance protocol utilizing cell-free DNA: A single-center experience. JHLT Open. 2024 May;4:100076. doi: 10.1016/j.jhlto.2024.100076
- Battes LC, Caliskan K, Rizopoulos D, et al. Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients. Transplantation. 2015 Mar;99(3):580-5. doi: 10.1097/tp.0000000000000378
- Moayedi Y, Fan CS, Tinckam KJ, Ross HJ, McCaughan JA. De novo donorspecific HLA antibodies in heart transplantation: do transient de novo DSA confer the same risk as persistent de novo DSA? Clin Transplant. 2018 Nov;32(11):
e13416 . doi: 10.1111/ctr.13416 - Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med. 2010 May 20;362(20):1890-900. doi: 10.1056/NEJMoa0912965
- Crespo-Leiro MG, Stypmann J, Schulz U, et al. Clinical Usefulness of Gene-Expression Profile to Rule Out Acute Rejection after Heart Transplantation: CARGO II. Eur Heart J. 2016 Sep 1;37(33):2591-601. doi: 10.1093/eurheartj/ehv682
- Kobashigawa J, Patel J, Azarbal B, et al. Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant. Circulation Hear Fail. 2015 May;8(3):557-64. doi: 10.1161/circheartfailure.114.001658
- Moayedi Y, Foroutan F, Miller RJH, et al. Risk Evaluation Using Gene Expression Screening to Monitor for Acute Cellular Rejection in Heart Transplant Recipients. J Heart Lung Transpl. 2019 Jan;38(1):51-8. doi: 10.1016/j.healun.2018.09.004
- FDA [Internet]. Silver Spring, MD: US Food and Drug Administration; c2025.
Cardiac Allograft Gene Expression Profiling Test System – Class II special Controls Guidance for Industry and FDA ; 2009 Oct 21 [cited 2025 Mar 23]. Available from:https://www.fda.gov/medical-devices/guidance-documents-medical-devices-and-radiation-emitting-products/cardiac-allograft-gene-expression-profiling-test-systems-class-ii-special-controls-guidance-industry - DeVlaminck I, Valantine HA, Snyder TM, et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med. 2014 Jun 18;6(241):241ra77. doi: 10.1126/scitranslmed.3007803
- Agbor-Enoh S, Shah P, Tunc I, et al. Cell-free DNA to detect heart allograft acute rejection. Circulation. 2021 Mar 23;143(12):1184-97. doi: 10.1161/circulationaha.120.049098
- Khush KK, Patel J, Pinney S, et al. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study. Am J Transplant. 2019 Oct;19(10):2889-99. doi: 10.1111/ajt.15339
- Kim PJ, Olymbios M, Siu A, et al. A novel donorderived cell-free DNA assay for the detection of acute rejection in heart transplantation. J Hear Lung Transplant. 2022 Jul;41(7):919-27. doi: 10.1016/j.healun.2022.04.002
- Henricksen EJ, Moayedi Y, Purewal S, et al. Combining donor derived cell free DNA and gene expression profiling for noninvasive surveillance after heart transplantation. Clin Transplant. 2023 Mar;37(3):
e14699 . doi: 10.1111/ctr.14699 - Grskovic M, Hiller DJ, Eubank LA, et al. Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients. J Mol Diagn. 2016 Nov;18(6):890-902. doi: 10.1016/j.jmoldx.2016.07.003
- Holzhauser L, DeFilippis EM, Nikolova A, et al. The End of Endomyocardial Biopsy?: A Practical Guide for Noninvasive Heart Transplant Rejection Surveillance. JACC Heart Fail. 2023 Mar;11(3):263-276. doi: 10.1016/j.jchf.2022.11.002
- Nikolova A, Agbor-Enoh S, Bos S, et al. European Society for Organ Transplantation (ESOT) Consensus Statement on the Use of noninvasive Biomarkers for Cardiothoracic Transplant Rejection Surveillance. Transpl Int. 2024 Jun 11;37:12445. doi: 10.3389/ti.2024.12445
- DePasquale EC, Ardehali A. Primary graft dysfunction in heart transplantation. Curr Opin Organ Transplant. 2018 Jun;23(3):286-294. doi: 10.1097/MOT.0000000000000523
- Badano LP, Miglioranza MH, Edvardsen T, et al.: Document reviewers. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation. Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):919-48. doi: 10.1093/ehjci/jev139
- Mena C, Wencker D, Krumholz HM, McNamara RL. Detection of Heart Transplant Rejection in Adults by Echocardiographic Diastolic Indices: A Systematic Review of the Literature. J Am Soc Echocardiogr. 2006 Oct;19(10):1295-300. doi: 10.1016/j.echo.2006.04.029
- Mingo-Santos S, Moñivas-Palomero V, Garcia-Lunar I, et al. Usefulness of Two-Dimensional Strain Parameters to Diagnose Acute Rejection after Heart Transplantation. J Am Soc Echocardiogr. 2015 Oct;28(10):1149-56. doi: 10.1016/j.echo.2015.06.005
- Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017 Oct 9;19(1):75. doi: 10.1186/s12968-017-0389-8. Erratum in: J Cardiovasc Magn Reson. 2018 Feb 7;20(1):9. doi: https://doi.org/10.1186/s12968-017-0408-9
- Han D, Miller RJH, Otaki Y, et al. Diagnostic Accuracy of Cardiovascular Magnetic Resonance for Cardiac Transplant Rejection: A Meta-Analysis. JACC Cardiovasc Imaging. 2021 Dec;14(12):2337-2349. doi: 10.1016/j.jcmg.2021.05.008
- Anthony C, Imran M, Pouliopoulos J, et al. Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation. Circulation. 2022 Jun 21;145(25):1811-1824. doi: 10.1161/CIRCULATIONAHA.121.057006
- Sciaccaluga C, Ghionzoli N, Mandoli GE, et al. The role of noninvasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences. Heart Fail Rev. 2022 Jul;27(4):1235-1246. doi: 10.1007/s10741-021-10155-0
- Prasad N, Harris E, DeFilippis EM, et al. PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes. J Nucl Med. 2025 Feb 3;66(2):264-270. doi: 10.2967/jnumed.124.268713
- Bravo PE, Bergmark BA, Vita T, et al. Diagnostic and prognostic value of myocardial blood flow quantification as noninvasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018 Jan 21;39(4):316-323. doi: 10.1093/eurheartj/ehx683
DOI: https://doi.org/10.14797/mdcvj.1578 | Journal eISSN: 1947-6108
Language: English
Page range: 51 - 57
Submitted on: Jan 31, 2025
Accepted on: Mar 11, 2025
Published on: May 15, 2025
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2025 Hatem Alansari, Janardhana R. Gorthi, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.